Transverse myelitis (TM) is a rare neurologic disorder of acute inflammation resulting in spinal cord injury. Chronic pain in TM is a significant detriment to quality of life. Spinal cord stimulation (SCS) is an emerging treatment that has shown significant efficacy in neuropathic pain. We present a 37-year-old man with a history of idiopathic thoracic TM and refractory chronic neuropathic pain who underwent an SCS trial. He reported 70% improvement during the trial and was subsequently implanted with an SCS. He continues to experience significant pain relief and functional improvement (>80%) with conventional paresthesia programming at the 9-month follow-up.
From the *Department of Anesthesia, Pain Medicine, University of California San Diego Health Center, La Jolla, California;
†Department of Pain Medicine, Sutter East Bay Medical Group, Berkeley, California.
Accepted for publication July 15, 2019.
Conflicts of Interest: See Disclosures at the end of the article.
Address correspondence to Rajiv Reddy, MD, Department of Anesthesia, Pain Medicine, University of California San Diego Health Center, La Jolla, CA 92037. Address e-mail to firstname.lastname@example.org.